42 results on '"Semlitsch, H. V."'
Search Results
2. Klinische und EEG/ERP-Mapping-Studien mit Vigabatrin bei Patienten mit therapieresistenten Epilepsien
3. ERP-Topographie bei Patientinnen mit menopausalem Syndrom
4. Klinische und EEG/ERP Mapping-Studien bei therapieresistenten Epilepsien unter Vigabatrin-Behandlung
5. Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry
6. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects
7. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression
8. Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study
9. Topographic mapping of long latency “cognitive” event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia
10. ERP-Topographie bei Patientinnen mit menopausalem Syndrom
11. Ein künstliches neuronales Netzwerk zur Klassifikation dementer Patienten basierend auf der topographischen Verteilung der langsamen EEG Aktivität
12. Estrogen, Vigilance, and Depression in the Menopause: Clinical and EEG Mapping Studies with Es-traderm TTS
13. P-74. EEG/EP Mapping in Menopausal Syndrome with and without Depression
14. Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300), eye blink rate and mood in young healthy subjects
15. PHARMACODYNAMICS OF VENLAFAXINE EVALUATED BY EEG BRAIN MAPPING, PSYCHOMETRY AND PSYCHOPHYSIOLOGY.
16. Cognitive Psychophysiology in Nootropic Drug Research: Effects of Ginkgo biloba on Event-related Potentials (P300) in Age-associated Memory Impairment.
17. Hormonal, syndromal and EEG mapping studies in menopausal syndrome patients with and without depression as compared with controls
18. Acute effects of the novel antidepressant venlafaxine on cognitive eventrelated potentials P300 eye blink rate and mood in young healthy subjects
19. P74 EEGEP Mapping in Menopausal Syndrome with and without Depression
20. Treatment of seasonal affective disorder with duloxetine: an open-label study.
21. Non-invasive localization of P300 sources in normal aging and age-associated memory impairment.
22. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography).
23. Structural and energetic processes related to P300: LORETA findings in depression and effects of antidepressant drugs.
24. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
25. [Possible confounding variables on the flicker-fusion frequency: temperament, well-being, cognitive information processing speed].
26. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA).
27. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 2. Effects of nootropic therapy in age-associated memory impairment.
28. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 1. Effects of normal aging.
29. Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.
30. Multichannel auditory event-related brain potentials: effects of normal aging on the scalp distribution of N1, P2, N2 and P300 latencies and amplitudes.
31. Discrimination between demented patients and normals based on topographic EEG slow wave activity: comparison between z statistics, discriminant analysis and artificial neural network classifiers.
32. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
33. [Clinical and EEG/ERP brain mapping studies with vigabatrin in therapy refractory epileptic patients].
34. Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG results.
35. Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology.
36. Amantadine infusions in mild dementia: acute double-blind placebo-controlled EEG mapping and psychometric studies.
37. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
38. Topographic mapping of cognitive event-related potentials in a double-blind, placebo-controlled study with the hemoderivative Actovegin in age-associated memory impairment.
39. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
40. Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS).
41. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP.
42. Psychophysiological research in psychiatry and neuropsychopharmacology. I. Methodological aspects of the Viennese Psychophysiological Test-System (VPTS).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.